Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Tetrylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.50 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | CES1 | P23141 | 2/20 | 0.38 |
| ▸ | CA4 | P22748 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.36 |
| ▸ | BBOX1 | O75936 | 3/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrylammonium SCHEMBL9312731 | 1.00 | CA1 (0.50) | CA1TSHRNFKB1KCNA1KDM4E | |
| Tetrylammonium SCHEMBL3361488 | 1.00 | CA1 (0.50) | CA1TSHRNFKB1KCNA1KDM4E | |
| Tetrylammonium SCHEMBL1870055 | 1.00 | CA1 (0.50) | CA1TSHRNFKB1KCNA1KDM4E | |
| Tetrylammonium SCHEMBL27456144 | 0.97 | CA1 (0.47) | CA1TSHRNFKB1KCNA1KDM4E | |
| Tetrylammonium SCHEMBL30349943 | 0.97 | CA1 (0.53) | CA1TSHRNFKB1KCNA1KDM4E | |
| Tetrylammonium SCHEMBL49874 | 0.97 | CA1 (0.53) | CA1TSHRNFKB1KCNA1KDM4E | |
| Tetrylammonium SCHEMBL3242574 | 0.94 | CA1 (0.50) | CA1TSHRNFKB1KCNA1KDM4E | |
| Tetrylammonium SCHEMBL29227388 | 0.91 | CA1 (0.47) | CA1TSHRNFKB1KCNA1KDM4E | |
| Tetrylammonium SCHEMBL16415823 | 0.89 | CA1 (0.40) | CA1TSHRNFKB1KCNA1KDM4E | |
| Tetrylammonium SCHEMBL21268041 | 0.88 | CA1 (0.44) | CA1TSHRNFKB1KCNA1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2038293-A1 | NON-ANIMAL BASED LACTOSE | Alberta Research Council, Inc. (CA) | 2009-03-25 | — | — | EP | claimed |
| WO-2008000082-A1 | NON-ANIMAL BASED LACTOSE | ALBERTA RESEARCH COUNCIL INC. (CA) | 2008-01-03 | — | — | WO | claimed |
| EP-2038293-A1 | NON-ANIMAL BASED LACTOSE | Alberta Research Council, Inc. (CA) | 2009-03-25 | — | — | EP | disclosed |
| WO-2008000082-A1 | NON-ANIMAL BASED LACTOSE | ALBERTA RESEARCH COUNCIL INC. (CA) | 2008-01-03 | — | — | WO | disclosed |
| EP-0916685-B1 | Branching agents for reactive extrusion | GEN ELECTRIC (US) | 2005-09-28 | — | — | EP | disclosed |
| US-6316405-B1 | CYCLOSPORIN A, POLYPEPTIDES, COMPONENT OF AMYLOID PLAQUES FOUND IN NEUROLOGICAL DISORDERS SUCH AS ALZHEIMER'S DISEASE, MULTIPLE SCLEROSIS, AND AMYOTROPHIC LATERAL SCLEROSIS. THE CONJUGATES ARE USEFUL IN THE TREATMENT OF NEUROLOGICAL | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2001-11-13 | — | — | US | disclosed |
| US-6270957-B1 | USEFUL IN THE TREATMENT AND PREVENTION OF HIV (HUMAN IMMUNODEFICIENCY VIRUS)-MEDIATED DISORDERS, INCLUDING AIDS (ACQUIRE IMMUNODEFICIENCY SYNDROME) | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2001-08-07 | — | — | US | disclosed |
| CN-1067396-C | Processes for producing N,N'-diffluorodiazoniabicyclo-alkane salts, intermediates int he synthesis of the same, target products, and application of the target products | DAIKIN IND LTD (JP) | 2001-06-20 | — | — | CN | disclosed |
| US-6087468-A | CROSSLINKING A POLYCARBONATE, ESTER INTERCHANGE, REMOVING SOLVENT AND MELT BLENDING | GENERAL ELECTRIC COMPANY (US) | 2000-07-11 | — | — | US | disclosed |
| EP-0916685-A1 | Branching agents for reactive extrusion | GENERAL ELECTRIC COMPANY (US) | 1999-05-19 | — | — | EP | disclosed |
| US-5892035-A | FLUORINATING THE CORRESPONDING DIAZABICYCLOALKALINE COMPOUND | DAIKIN INDUSTRIES LTD. (JP) | 1999-04-06 | — | — | US | disclosed |
| WO-1999010374-A1 | CYCLOSPORIN A CONJUGATES AND USES THEREFOR | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1999-03-04 | — | — | WO | disclosed |
| WO-1999010373-A1 | NON-IMMUNOSUPPRESSIVE CYCLOSPORINS AND THEIR USE IN THE PREVENTION AND TREATMENT OF HIV INFECTION | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1999-03-04 | — | — | WO | disclosed |
| CN-1165516-A | Processes for producing N,N'-diffluorodiazoniabicyclo-alkane salts, intermediates int he synthesis of the same, target products, and application of the target products | DAIKIN IND LTD (JP) | 1997-11-19 | — | — | CN | disclosed |
| EP-0785199-A1 | PROCESSES FOR PRODUCING N,N'-DIFLUORODIAZONIABICYCLO-ALKANE SALTS, INTERMEDIATES IN THE SYNTHESIS OF THE SAME, TARGET PRODUCTS, AND APPLICATION OF THE TARGET PRODUCTS | DAIKIN INDUSTRIES, LIMITED (JP) | 1997-07-23 | — | — | EP | disclosed |
| EP-0264183-B1 | DERIVATIVES OF 5-METHYL-10,11-DIHYDRO-5H-DIBENZO-(A,D) CYCLOHEPTEN-5,10-IMINE | MERCK & CO. INC. (US) | 1992-01-15 | — | — | EP | disclosed |
| US-4870079-A | ANTICONVULSANTS, ANTAGONISTS OF N-METHYL-D-ASPARTATE | MERCK & CO., INC. (US) | 1989-09-26 | — | — | US | disclosed |
| EP-0264183-A1 | Derivatives of 5-methyl-10,11-dihydro-5H-dibenzo-(a,d) cyclohepten-5,10-imine | MERCK & CO. INC. (US) | 1988-04-20 | — | — | EP | disclosed |